Korea Gains Speed In Race For NASH Therapies
Major Deals And Growing Pipeline
NASH has become a major therapeutic focus for pharma firms in South Korea, where companies are speeding up development and expanding their pipelines after Yuhan’s sizable global license deals last year.
